Ruth Geraldes
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: A multicentric observational study
Geraldes, Ruth; Robson, Joanna C; Santos, Monica; Ponte, Cristina; Craven, Anthea; Barra, Lillian; Hammam, Nevin; Springer, Jason; Henes, Jöerg; Hocevar, Alojzija; Putaala, Jukka; Santos, Ernestina; Rajasekhar, Liza; Daikeler, Thomas; Karadag, Omer; Costa, Andreia; Khalidi, Nader; Pagnoux, Christian; Canhão, Patrícia; Melo, Teresa Pinho E; Fonseca, Ana Catarina; Ferro, José M; Fonseca, João Eurico; Suppiah, Ravi; Watts, Richard A; Grayson, Peter; Merkel, Peter A; Luqmani, Raashid A
Authors
Jo Robson Jo.Robson@uwe.ac.uk
Consultant Associate Professor in Rheumatology
Monica Santos
Cristina Ponte
Anthea Craven
Lillian Barra
Nevin Hammam
Jason Springer
Jöerg Henes
Alojzija Hocevar
Jukka Putaala
Ernestina Santos
Liza Rajasekhar
Thomas Daikeler
Omer Karadag
Andreia Costa
Nader Khalidi
Christian Pagnoux
Patrícia Canhão
Teresa Pinho E Melo
Ana Catarina Fonseca
José M Ferro
João Eurico Fonseca
Ravi Suppiah
Richard A Watts
Peter Grayson
Peter A Merkel
Raashid A Luqmani
Abstract
Objectives: The cerebral vessels may be affected in primary systemic vasculitis (PSV), but little is known about cerebrovascular events (CVEs) in this population. This study aimed to determine the frequency of CVEs at the time of diagnosis of PSV, to identify factors associated with CVEs in PSV, and to explore features and outcomes of stroke in patients with PSV. Methods: Data from adults newly diagnosed with PSV within the Diagnostic and Classification Criteria in VASculitis (DCVAS) study were analysed. Demographics, risk factors for vascular disease, and clinical features were compared between patients with PSV with and without CVE. Stroke subtypes and cumulative incidence of recurrent CVE during a prospective 6-month follow-up were also assessed. Results: The analysis included 4828 PSV patients, and a CVE was reported in 169 (3.50%, 95% CI 3.00–4.06): 102 (2.13% 95% CI 1.73–2.56) with stroke and 81 (1.68% 95% CI 1.33–2.08) with transient ischemic attack (TIA). The frequency of CVE was highest in Behçet’s disease (9.5%, 95% CI 5.79–14.37), polyarteritis nodosa (6.2%, 95% CI 3.25–10.61), and Takayasu’s arteritis (6.0%, 95% CI 4.30–8.19), and lowest in microscopic polyangiitis (2.2%, 95% CI 1.09–3.86), granulomatosis with polyangiitis (2.0%, 95% CI 1.20–3.01), cryoglobulinaemic vasculitis (1.9%, 95% CI 0.05–9.89), and IgA-vasculitis (Henoch-Schönlein) (0.4%, 95% CI 0.01–2.05). PSV patients had a 11.9% cumulative incidence of recurrent CVE during a 6-month follow-up period. Conclusion: CVEs affect a significant proportion of patients at time of PSV diagnosis, and the frequency varies widely among different vasculitis, being higher in Behçet’s. Overall, CVE in PSV is not explained by traditional vascular risk factors and has a high risk of CVE recurrence.
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 10, 2024 |
Online Publication Date | Mar 12, 2024 |
Deposit Date | Feb 13, 2024 |
Publicly Available Date | Apr 12, 2024 |
Journal | Journal of Neurology |
Print ISSN | 0340-5354 |
Electronic ISSN | 1432-1459 |
Publisher | Springer |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1007/s00415-024-12251-1 |
Keywords | Stroke, Transient ischaemic attack, Cerebrovascular event, Primary systemic vasculitis |
Public URL | https://uwe-repository.worktribe.com/output/11702979 |
Files
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: A multicentric observational study
(1.4 Mb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
This article is available via the publisher at: https://doi.org/10.1007/s00415-024-12251-1
You might also like
P041 Health-related quality of life in patients receiving glucocorticoids for a rheumatic disease and associated factors: A cross-sectional study
(2024)
Presentation / Conference Contribution
P186 Impact of glucocorticoids on appearance and sense of self in rheumatic diseases
(2024)
Presentation / Conference Contribution
Downloadable Citations
About UWE Bristol Research Repository
Administrator e-mail: repository@uwe.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search